Company Analysis Ardent Health Partners, LLC
1. Summary
Advantages
- Price (15.21 $) is less than fair price (21.23 $)
- The stock's return over the last year (-17.16%) is higher than the sector average (-24.42%).
- The company's current efficiency (ROE=19.19%) is higher than the sector average (ROE=-73.93%)
Disadvantages
- Dividends (0%) are below the sector average (1.36%).
- Current debt level 46.05% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Ardent Health Partners, LLC | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.4% | -0.1% | -0.6% |
| 90 days | 46.9% | -18.8% | 3.1% |
| 1 year | -17.2% | -24.4% | 12% |
ARDT vs Sector: Ardent Health Partners, LLC has outperformed the "Healthcare" sector by 7.25% over the past year.
ARDT vs Market: Ardent Health Partners, LLC has significantly underperformed the market by -29.17% over the past year.
Stable price: ARDT is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ARDT with weekly volatility of -0.3301% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (15.21 $) is lower than the fair price (21.23 $).
Price significantly below the fair price: The current price (15.21 $) is 39.6% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (11.59) is lower than that of the sector as a whole (28.54).
P/E vs Market: The company's P/E (11.59) is lower than that of the market as a whole (55.86).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.6) is lower than that of the sector as a whole (10.22).
P/BV vs Market: The company's P/BV (1.6) is lower than that of the market as a whole (17.51).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.4087) is lower than that of the sector as a whole (4.26).
P/S vs Market: The company's P/S indicator (0.4087) is lower than that of the market as a whole (27.76).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.49) is lower than that of the sector as a whole (18.11).
EV/Ebitda vs Market: The company's EV/Ebitda (7.49) is lower than that of the market as a whole (32.47).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by 0% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (0%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0.1718%).
6.4. ROE
ROE vs Sector: The company's ROE (19.19%) is higher than that of the sector as a whole (-73.93%).
ROE vs Market: The company's ROE (19.19%) is lower than that of the market as a whole (38.91%).
6.6. ROA
ROA vs Sector: The company's ROA (4.34%) is lower than that of the sector as a whole (6.84%).
ROA vs Market: The company's ROA (4.34%) is lower than that of the market as a whole (11.35%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (21.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.27%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.36%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
